Basal cell carcinoma

  • D. Roseeuw
  • A. D. Katsambas
  • J. P. Hachem


Basal cell carcinoma (BCC), is a slow-growing locally invasive epidermal tumour and metastases are extremely rare. BCC, the most common malignancy among Caucasians, is also known as basalioma, basal cell epithelioma, basal cell cancer, rodent ulcer, rodent cancer and non-Malpighian epithelioma.


Basal Cell Carcinoma Xeroderma Pigmentosum High Cure Rate Excision Surgery Superficial Basal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Bernardeau K, Derancourt C, Cambie M et al. Cryosurgery of basal cell carcinoma: a study of 358 patients. Ann Dermatol Venereol 2000; 127: 175–9.PubMedGoogle Scholar
  2. Berridge JK, Morgan DA. A comparison of late cosmetic results following two different radiotherapy techniques for treating basal cell carcinoma. Clin Oncol (R Coll Radio!) 1997; 9: 400–2.CrossRefGoogle Scholar
  3. Beutner KR, Geisse JK, Heiman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002–7.PubMedCrossRefGoogle Scholar
  4. Buechner SA, Wernli M, Harr T, Hahn S, Itin P, Erb P. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas) -CD95 ligand-induced suicide. J Clin Invest 1997; 100: 2691–6.PubMedCrossRefGoogle Scholar
  5. Caccialanza M, Piccinno R, Beretta M, Gnecchi L. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol 1999; 41: 589–94.PubMedGoogle Scholar
  6. Dogan B, Harmanyeri Y, Baloglu H, Oztek I. Intralesional alfa-2a interferon therapy for basal cell carcinoma. Cancer Lett 1995; 91: 215–19.PubMedCrossRefGoogle Scholar
  7. Duvic M, Asano AT, Hager C, Mays S. The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol 1998; 39: S129 - S132.PubMedCrossRefGoogle Scholar
  8. Griep C, Davelaar J, Scholten AN, Chin A, Leer JW. Electron beam therapy is not inferior to superficial X-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1347–50.PubMedCrossRefGoogle Scholar
  9. Ikic D, Padovan I, Pipic N et al. Interferon reduces recurrences of basal cell and squamous cell cancers. Int J Dermatol 1995; 34: 58–60.PubMedCrossRefGoogle Scholar
  10. Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB. Life-threatening toxicity in a dihydropyrimidine dehydrogenasedeficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 1999; 5: 2006–11.PubMedGoogle Scholar
  11. Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577–8.PubMedCrossRefGoogle Scholar
  12. Kaplan B, Moy RL. Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. Dermatol Surg 2000; 26: 1037–40.PubMedCrossRefGoogle Scholar
  13. Kuflike EG, Gage AA. The five year cure rate achieved by cryosurgery for cancer. J Am Acad Dermatol 1991; 24: 1002–4.CrossRefGoogle Scholar
  14. Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998; 39: S62–6.PubMedCrossRefGoogle Scholar
  15. Miller BH, Shavin JS, Cognetta A et al. Nonsurgical treatment of basal cell carcinomas with interlesional 5-fluorouracil/epinephrine infectable gel. JAm Acad Dermatol 1997; 36: 72–7.CrossRefGoogle Scholar
  16. Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum based cytotoxic therapy in basal cell carcinoma. Acta Oncol 1996; 35: 677–82.PubMedCrossRefGoogle Scholar
  17. Peck GL, DiGiovanna JJ, Sarnoff DS et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988; 19: 176–85.PubMedCrossRefGoogle Scholar
  18. Penis K, Fargnoli MC, Chimenti S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Pug! J Med 1999; 341: 1767–8.CrossRefGoogle Scholar
  19. Petit JY, Avril MF, Margulis A et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000; 105: 2544–51.PubMedCrossRefGoogle Scholar
  20. Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. Dermatologica 1979; 158: 368–72.PubMedCrossRefGoogle Scholar
  21. Romagosa R, Saap L, Givens M et al. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier. Dermatol Surg 2000; 26: 338–40.PubMedCrossRefGoogle Scholar
  22. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated primary basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315–28.PubMedGoogle Scholar
  23. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424–31.PubMedGoogle Scholar
  24. Sakata K, Aoki Y, Kumakura Yet al. Radiation therapy for patients with xeroderma pigmentosum. Radiat Med 1996; 14: 87–90.PubMedGoogle Scholar
  25. Silverman MK, Kopf AW, Bart RS, Grin CM, Leven-stein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992; 18: 471–6.PubMedGoogle Scholar
  26. Suhge d’Aubermont PC, Bennett RG. Failure of curettage and electrodesiccation for removal of basal cell carcinoma. Arch Dermatol 1984; 120: 1456–60.PubMedCrossRefGoogle Scholar
  27. Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26: 759–64.PubMedCrossRefGoogle Scholar
  28. Thissen MR, Schroeter CA, Neumann HA. Photo-dynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338–9.PubMedCrossRefGoogle Scholar
  29. Wagner RF, Cottel WI. Multifocal recurrent basal cell carcinoma following primary tumour treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987; 17: 1047–9.PubMedCrossRefGoogle Scholar
  30. Weinstein GD, Krueger GG, Lowe NJ et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. Am Acad Dermatol 1997; 37: 85–92.CrossRefGoogle Scholar
  31. Wennberg AM, Lindholm LE, Alpsten M, Larkö O. Treatment of surperficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996; 288: 561–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • D. Roseeuw
  • A. D. Katsambas
  • J. P. Hachem

There are no affiliations available

Personalised recommendations